Induced pluripotent stem cells: a new era for hepatology

Journal of Hepatology
Samira AsgariHossein Baharvand

Abstract

Stem cell transplantation has been proposed as an attractive alternative approach to restore liver mass and function. Recent progress has been reported on the generation of induced pluripotent stem (iPS) cells from somatic cells. Human-iPS cells can be differentiated towards the hepatic lineage which presents possibilities for improving research on diseases, drug development, tissue engineering, the development of bio-artificial livers, and a foundation for producing autologous cell therapies that would avoid immune rejection and enable correction of gene defects prior to cell transplantation. This focused review will discuss how human iPS cell advances are likely to have an impact on hepatology.

References

Jan 1, 1977·The Journal of Cell Biology·L J Crane, D L Miller
Jun 1, 1992·Experimental Cell Research·J Z TongF Alvarez
Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E A RobertsS Yang
May 15, 1998·The New England Journal of Medicine·I J FoxS C Strom
Nov 6, 1998·Science·J A ThomsonJ M Jones
Jun 1, 1999·Seminars in Liver Disease·S C StromI J Fox
Sep 29, 2001·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·G V MazariegosJ F Patzer
Jan 5, 2002·Biomaterials·Jun YangToshihiro Akaike
Feb 7, 2002·Lancet·Maurizio MuracaAlberto B Burlina
Aug 6, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tuan Huy NguyenDidier Trono
Apr 16, 2003·Cell Transplantation·Lakshmi RambhatlaMelissa K Carpenter
Feb 19, 2004·Nature Reviews. Genetics·Stefan Grimm
Jun 12, 2004·Cell Transplantation·Hitoshi ShirahashiMark A Zern
Jul 24, 2004·Differentiation; Research in Biological Diversity·Neta LavonNissim Benvenisty
Dec 23, 2004·Transplantation·Anil DhawanGiorgina Mieli-Vergani
Feb 12, 2005·Reproductive Biomedicine Online·Y VerlinskyA Kuliev
May 11, 2005·Cell Transplantation·Giovanni AmbrosinoLorenzo D'Antiga
Jul 6, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Xavier StéphenneEtienne M Sokal
Oct 20, 2005·Journal of Bioscience and Bioengineering·Jung-Keug Park, Doo-Hoon Lee
Oct 28, 2005·The American Journal of Pathology·Satdarshan P S MongaJörg C Gerlach
Dec 15, 2005·Journal of Hepatology·José M MiróUNKNOWN Hospital Clinic Olt In Hiv Working Group
Jan 26, 2006·Stem Cells and Development·Robert E SchwartzDan S Kaufman
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emiliano Calvo, José Baselga
Aug 8, 2006·The International Journal of Developmental Biology·Hossein BaharvandAli Farrokhi
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Jan G HengstlerMarc-Alexander von Mach
Oct 25, 2006·Transplantation·Andrea SchneiderBernd Panning
Nov 4, 2006·Pharmacology & Therapeutics·Sian E HardingJulia Gorelik
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jun CaiHongkui Deng
Jul 17, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Mauro AliniHans Joachim Wilke
Sep 1, 2007·Nature Cell Biology·Nadia Rosenthal, Steve Brown

❮ Previous
Next ❯

Citations

Oct 20, 2010·Cell and Tissue Research·Caroline Beth Sangan, David Tosh
Dec 19, 2012·Molecular Biotechnology·Faranak FattahiHossein Baharvand
Jun 1, 2012·Hepatology International·Min ZhangJun Chen
Nov 10, 2011·Stem Cells and Development·Alexandre Teixeira VessoniOswaldo Keith Okamoto
Jul 21, 2011·British Medical Bulletin·Massoud VosoughHossein Baharvand
Nov 9, 2011·Journal of Visualized Experiments : JoVE·Claire N MedineDavid C Hay
Jan 9, 2013·Annual Review of Pharmacology and Toxicology·Dagmara SzkolnickaDavid C Hay
Nov 15, 2011·Stem Cell Reviews and Reports·Samira AsgariHossein Baharvand
Mar 1, 2012·Canadian Journal of Physiology and Pharmacology·Stefano Pietronave, Maria Prat
Mar 5, 2014·Expert Opinion on Drug Metabolism & Toxicology·Manuela de Lima Toccafondo Vieira, Carlos Alberto Tagliati
Feb 27, 2016·Journal of Hepatology·Zara HannounAnne Dubart-Kupperschmitt
Jul 4, 2012·The Veterinary Journal·Rajagopal N AravalliClifford J Steer
Jan 6, 2015·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Y L FangGodbey W T
May 29, 2013·Journal of Cellular and Molecular Medicine·Zhiqiang LiuChangyong Wang
Jun 30, 2015·Journal of Digestive Diseases·Dan YangMu Han Lü
Dec 3, 2014·Journal of Hepatology·Koen VercauterenPhilip Meuleman
Sep 18, 2012·Theriogenology·N Rodriguez-OsorioE Memili
Apr 30, 2016·Canadian Journal of Physiology and Pharmacology·Mária CsöbönyeiováL'uboš Danišovič
Aug 18, 2016·Hepatology International·Namita Roy-ChowdhuryJayanta Roy-Chowdhury
Nov 7, 2012·Cell Transplantation·Yuan-Sheng LiTzyy-Wen Chiou
Jan 1, 2014·Journal of Clinical Medicine·Yue YuScott L Nyberg
Jan 6, 2016·Biomedicines·Clara NicolasScott L Nyberg
Dec 1, 2013·Regenerative Medicine Research·Zhiqiang LiuChangyong Wang
Nov 5, 2014·Cell Medicine·Yue YuScott L Nyberg
Jul 3, 2020·Cells, Tissues, Organs·Jia YaoScott L Nyberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Dimitry A Chistiakov, Pavel A Chistiakov
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Gareth J SullivanIan Wilmut
American Journal of Physiology. Gastrointestinal and Liver Physiology
Donna M DalgettyDavid C Hay
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Karim Si-TayebStephen A Duncan
© 2021 Meta ULC. All rights reserved